title: [Saforelle - a new approach to treat vaginitis].
abstract: Infections of the vulva and vagina are one of the most common gynecological diseases. They can be determined by a variety of physical, chemical and biological factors. The main risk factors contributing to vaginitis are aerobic and anaerobic bacterias, fungal and viral infections, and irritants. Subjective complaints are pruritus, vulvar and/or perivulvar erytema and different in volume and characterization discharge. Excepting etiological treatment in most cases it is necessary to use additional agents, for example Saforelle.
authors.forename: V
authors.initials: V
authors.lastname: Karamisheva
authors.forename: A
authors.initials: A
authors.lastname: Nachev
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use; D000982:Antipruritics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D014621:Vagina / Q000382:microbiology*; D014622:Vaginal Creams, Foams, and Jellies / Q000627:therapeutic use*; D014627:Vaginitis / Q000188:drug therapy* / Q000382:microbiology*; D014844:Vulva / Q000382:microbiology; D014847:Vulvitis / Q000188:drug therapy / Q000382:microbiology
chemical_list: D000890:Anti-Infective Agents; D000982:Antipruritics; D014622:Vaginal Creams, Foams, and Jellies; D008795:Metronidazole